Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Bionano Genomics (NASDAQ: BNGO): Optical Genome Mapping's Path to a Leaner Model

Bionano Genomics (NASDAQ: BNGO) develops and sells tools for structural variation analysis of the genome. Its optical genome mapping (OGM) systems, historically marketed under the Saphyr and later Stratys names, alongside the VIA software platform, are used by researchers and clinical labs to detect …

Nitish Kishor | 10 September 2026

Intuitive Surgical (NASDAQ: ISRG): The da Vinci 5 Rollout Continues

Intuitive Surgical (NASDAQ: ISRG) designs, manufactures and markets the da Vinci surgical systems used in minimally invasive procedures across urology, gynecology, general surgery and other specialties, as well as the Ion endoluminal system for minimally invasive lung biopsy. The business model blends large capital …

Nitish Kishor | 10 September 2026

Abbott Laboratories (NYSE: ABT): FreeStyle Libre Anchors a Diversified Portfolio

Abbott Laboratories (NYSE: ABT) operates across four broad segments: Medical Devices, Diagnostics, Nutrition, and Established Pharmaceuticals. Its single most important growth engine in recent years has been the FreeStyle Libre continuous glucose monitoring franchise, one of the most successful medical-device product lines in the …

Nitish Kishor | 10 September 2026

ProKidney Corp (NASDAQ: PROK): Rilparencel's Path Through Late-Stage Testing

ProKidney Corp (NASDAQ: PROK) is developing rilparencel, an autologous cell therapy created from a patient's own kidney cells and intended to preserve or improve renal function in chronic kidney disease, particularly in patients with diabetes and advanced disease. The company, which became publicly traded …

Nitish Kishor | 10 September 2026

Akari Therapeutics (NASDAQ: AKTX): Pivoting From Rare Disease to Oncology ADCs

Akari Therapeutics Plc (NASDAQ: AKTX) is a UK-based clinical-stage biopharmaceutical company whose American Depositary Shares trade on Nasdaq. Historically, Akari was known for nomacopan, a complement C5 and leukotriene B4 inhibitor studied in rare inflammatory and immune-mediated conditions. Following a reverse-merger transaction that combined …

Nitish Kishor | 10 September 2026

Milestone Scientific (NYSE American: MLSS): A Debt-Free Balance Sheet and Medical Segment Growth

Headquartered in Livingston, New Jersey, Milestone Scientific designs and commercializes computer-controlled drug-delivery and injection systems for medical and dental use. Its core platforms include the CompuFlo Epidural instrument, which provides real-time pressure guidance during epidural placement, and The Wand/STA single-tooth anesthesia system used in …

Nitish Kishor | 10 September 2026

Vicapsys Life Sciences (OTC: VICP): Understanding the Deregistered Biomaterials Developer

Vicapsys Life Sciences is a Florida-incorporated, Georgia-based development-stage life-sciences company focused on biomaterials for transplantation and surgical applications. Its lead concept, VICAPSYN, is an immunoisolation technology intended to protect transplanted cells, such as insulin-producing islet cells, from immune rejection, while a second program, VYBRIN, …

Nitish Kishor | 10 September 2026

Sonoma Pharmaceuticals (NASDAQ: SNOA): A Turn Toward Positive Adjusted EBITDA

Sonoma Pharmaceuticals, based in Boulder, Colorado, develops and manufactures products built on its stabilized hypochlorous acid technology, marketed under brands including Microcyn and Microdacyn for wound care and related indications. On June 16, 2026, the company reported fiscal 2026 results, for its fiscal year …

Nitish Kishor | 10 September 2026

KORU Medical Systems (NASDAQ: KRMD): A Return to Profitability in Subcutaneous Delivery

KORU Medical Systems, headquartered in Mahwah, New Jersey, develops and manufactures subcutaneous infusion systems used to deliver medications such as immunoglobulin therapies outside the hospital, led by its FREEDOM syringe infusion platform and the FreedomEDGE device. On August 5, 2026, the company reported second-quarter …

Nitish Kishor | 10 September 2026

Reflect Scientific (OTC: RSCF): Cryogenic Freezers Meet Data-Center Cooling

Reflect Scientific, Inc. (OTC: RSCF), based in Orem, Utah, designs and sells scientific equipment for the life-science andManufacturingsectors, most notably its Cryometrix ultra-low-temperature and blast freezers used to store blood, vaccines and other temperature-sensitive products, along with laboratory consumables. Its most recent operational update …

Nitish Kishor | 10 September 2026
Support

Hi! How can we help you today?

Loading…